[Corticoid-therapie with fluocortolone (Ultralan)].
D001714:Bipolar Disorder / Q000139:chemically induced; D003480:Cushing Syndrome / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000139:chemically induced; D004487:Edema / Q000139:chemically induced; D004679:Encephalomyelitis / Q000188:drug therapy; D005094:Exophthalmos / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D011115:Polyneuropathies / Q000188:drug therapy; D011605:Psychoses, Substance-Induced
D005938:Glucocorticoids
Kortikoid-Therapie mit Fluocortolon (Ultralan)